AbbVie | ABBV - Zysk Brutto Na Sprzedaży

Cena Akcji
197.69
Dzienna Zmiana
0.31 0.16%
Miesięcznie
-7.24%
Rocznie
2.16%
Q2 Prognozy TE
194.46




Zysk Brutto Na Sprzedaży Zmiana Data
AbbVie USD 10.47B 605M 2025-09
Abbott USD 5.86B 675M 2026-03
ALKERMES USD 338.34M 72.51M 2025-12
Amgen USD 6.48B 307M 2025-09
AstraZeneca USD 12.39B 5M 2025-12
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Coherus Biosciences USD 8.7M 853K 2025-12
Eisai JPY 168.85B 17.02B 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Infinity Pharmaceuticals USD 231K 59K 2023-06
J&J USD 17.24B 642M 2026-03
Medtronic USD 5.41B 27M 2025-12
Merck USD 13.42B 431M 2025-09
Neurocrine Biosciences USD 787.9M 7M 2025-12
Novartis USD 10.25B 570M 2025-12
Pacira USD 142.25M 11.34M 2025-12
Perrigo USD 362.2M 14.9M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
UCB EUR 3.19B 621M 2025-12
Ultragenyx Pharmaceutical USD 178M 46.06M 2025-12
United Therapeutics USD 315.5M 286.6M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12
Zoetis USD 1.64B 73M 2025-12